Company Overview

Development Stage

About the Company

[Summary] Top 30 enterprise in China's pharmaceutical industry

Wuhan Renfu Pharmaceutical Co., Ltd. is a leading enterprise in Hubei Province's pharmaceutical industry and a Top 14 enterprise in China's pharmaceutical industry. It is a wholly-owned subsidiary of Humanwell Healthcare (Group) Co., Ltd. (referred to as "Humanwell Healthcare", stock code 600079). The company's predecessor was Wuhan Yangtze River Biochemical Pharmaceutical Factory, established in 1985. The company produces biochemical drugs and chemical drugs, and has dosage forms including lyophilized powder for injection, small volume injection, suppository, oral suspension, capsule, tablet and granule, and all dosage forms passed the new version GMP certification in 2012. Main products include: Oxcarbazepine Tablets, Deproteinized Calf Blood Extract Injection, Ibuprofen Suspension, Doxofylline for Injection, Three-dimensional Nystatin Suppository, Acetyl Kitasamycin Capsules, Finasteride Capsules, etc. Over the years, the company's achievements have been fully recognized by society, the government and the industry, and it has won many honors such as "Hubei Best Investment Credit Enterprise", "Hubei Pharmaceutical Market Quality Assurance Integrity Enterprise", "Hubei Market Industry Top Ten Credit Unit", "Donghu Development Zone Gazelle Enterprise" and others. In 2014, the company continued to be recognized as a "High-tech Enterprise" and "Central Nervous System Drug Engineering Research Center". In 2015, the company was rated as "Hubei Province Pharmaceutical Industry Growth-oriented Outstanding Enterprise Brand". "Wanyi" Oxcarbazepine Tablets were rated as "National Key New Product" and "Wuhan Independent Innovation Product", and "Diernuo" Ibuprofen Suspension has been recognized as a famous trademark of Hubei Province for 5 consecutive years. With more than 30 years of pharmaceutical experience, the company adheres to Humanwell's corporate spirit of "innovation, realism, sincerity, perseverance, unity", takes "making safe and effective drugs, creating value for patients" as its mission, follows a professional development path, focuses on central nervous system drugs and biochemical drugs, and also covers women's and children's medication. While creating value for society, shareholders and employees, it makes outstanding contributions to human health!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Renfu Pharmaceutical How Fast Is Hiring Growing? (17 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 14%
  • 2024: Down 36%
  • 2023: Up 350%
  • 2022: Down 79%
Renfu Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Renfu Pharmaceutical Campus Recruitment & Advanced Degree Talent Demand
Graduates 1 Master's 2
Note: How fast is hiring at Wuhan Renfu Pharmaceutical Co., Ltd. growing? Renfu Pharmaceutical2025: 66 openings (up 14%), 2024: 58 openings (down 36%), 2023: 90 openings (up 350%), 2022: 20 openings (down 79%), 2021: 96 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Renfu Pharmaceutical Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
Renfu Pharmaceutical Master's Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Wuhan Renfu Pharmaceutical Co., Ltd. growing? Renfu PharmaceuticalMaster's recruitment over the years: 2026: 2 openings (down 23%), 2023: 4 openings (up 350%), 2022: 3 openings (down 79%), 2021: 1 openings.

Renfu Pharmaceutical Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Renfu Pharmaceutical Doctoral Hiring by Year: 2023 — 10 more jobs than 2022
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Wuhan Renfu Pharmaceutical Co., Ltd. growing? Renfu PharmaceuticalDoctorate recruitment over the years: 2023: 11 openings (up 350%), 2022: 1 openings (down 79%), 2021: 1 openings.

Renfu Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Wuhan Renfu Pharmaceutical Co., Ltd.? Based on an analysis of Renfu Pharmaceutical's job postings over the past year, "医疗卫生/美容保健类" demand: 26.9%, "生物/制药/化工/环保类": 14.9%, "其他(研发和技术类)": 3%, "科研类": 3%. For reference only.

Renfu Pharmaceutical — What Are the Salaries Like? (67 records)

Manage
salary range: 3K - 15K, 83.6% of roles pay ¥6-15K
Note: salary statistics are based on 67 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Wuhan Renfu Pharmaceutical Co., Ltd.?Renfu Pharmaceutical83.6% of positions earn 6-15K, Fresh graduate salary: ¥9.0K。销售类 average salary ¥10.0K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Renfu Pharmaceutical

(More)
Are salaries high at Wuhan Renfu Pharmaceutical Co., Ltd.? We provide: 医药代表,临床,招商,操作员,环保,研究员,药品生产,qc,业务代表,人事,分析,制剂研究,学术专员,推广,纯化技术员,药学,质量,销售. Click to view detailed salary analysis by job.

Renfu Pharmaceutical honors, qualifications & industry associations

Renfu Pharmaceutical Related Industry Tags

Job Category

  • 销售类
    80.6% of total 80.6%
  • 医疗卫生/美容保健类
    26.9% of total 26.9%
  • 生物/制药/化工/环保类
    14.9% of total 14.9%
  • 技工类
    6% of total 6%

Education

  • 大专
    83.6% of total 83.6%
  • 本科
    10.4% of total 10.4%
  • 硕士
    3% of total 3%
  • 高中
    1.5% of total 1.5%

Experience

  • 1-3年
    83.6% of total 83.6%
  • 不限
    11.9% of total 11.9%
  • 3-5年
    3% of total 3%
  • 应届生
    1.5% of total 1.5%
View Detailed Analysis

What does Wuhan Renfu Pharmaceutical Co., Ltd. require? Who is Renfu Pharmaceutical hiring? Renfu Pharmaceutical recruitment: 销售类占比最多占80.6%,其次是医疗卫生/美容保健类占26.9%. What education can get in at Renfu Pharmaceutical? 大专占比最多占83.6%,其次是本科占10.4%. High education required at Renfu Pharmaceutical? 硕士占3%. Work experience required at Renfu Pharmaceutical? 1-3年占比最多占83.6%,其次是不限占11.9%. Where are the job locations at Renfu Pharmaceutical? 武汉占比最多占13.4%,其次是鄂州占7.5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 26,000万(元)
Legal Representative: 唐维
Date Established:
Credit Code: 914201003001966747
Registered Address: 湖北省武汉东湖新技术开发区生物园路8号

Partners & Suppliers

山东新华制药向武汉人福药业供应原料药 Source
供应商 原料药
武汉人福药业向其销售药品 Source
合作客户 医药商业
浙江海正向武汉人福药业提供原料药 Source
供应商 原料药
武汉人福药业向其供应化学药制剂 Source
合作客户 医药商业
武汉人福药业通过国药控股覆盖医院终端 Source
合作客户 医药商业

People who follow Renfu Pharmaceutical also follow

Renfu Pharmaceutical Competitors (Similar Companies)

“Leading enterprise in Hubei pharmaceutical industry, one of China's to”
新药研发 医药工业 麻醉药 试剂
“Writing memories with chips, letting the world's beauty last forever”
制药/药业 原料药 麻醉药 医药
生殖健康 生产 药物制剂 优生优育
“Dietary lipid nutrients and solutions”
“A technology-driven international pharmaceutical enterprise”
“Mainly engaged in the research, development and production of active p”
麻醉药 药物研发 医药中间体 抗肿瘤药
“Making drugs and treatments accessible to all”
制药/药业 医药 功能食品 牛磺酸
“Anorectal health solution provider”
“A large private modern pharmaceutical distribution enterprise in China”
“Making drugs and cures accessible to all”
制药/药业 生产 原料药 环境工程设计

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates